Preclinical safety and biodistribution of CRISPR targeting SIV in non-human primates
"Taken together, these results demonstrate safety, biodistribution, and in vivo proviral #DNA editing following IV administration of EBT-001, supporting the further development of CRISPR-based gene editing as a potential therapeutic approach for #HIV in humans..."
Another miracle.
https://www.nature.com/articles/s41434-023-00410-4
Mark Pesce /
npub13v…7ac7t
2023-08-20 08:19:45
Author Public Key
npub13v80f8g3c9rkxnlgrewl23zq0u66cr9qr55gpqk62aksgp8mhk8s07ac7tPublished at
2023-08-20 08:19:45Event JSON
{
"id": "f7f781c57b5f224e30bd1153942762ab7bcbf597e4e81e319f835bd2afb822e1",
"pubkey": "8b0ef49d11c147634fe81e5df544407f35ac0ca01d288082da576d0404fbbd8f",
"created_at": 1692519585,
"kind": 1,
"tags": [
[
"t",
"dna"
],
[
"t",
"hiv"
],
[
"proxy",
"https://arvr.social/users/mpesce/statuses/110920963541286625",
"activitypub"
]
],
"content": "Preclinical safety and biodistribution of CRISPR targeting SIV in non-human primates\n\n\"Taken together, these results demonstrate safety, biodistribution, and in vivo proviral #DNA editing following IV administration of EBT-001, supporting the further development of CRISPR-based gene editing as a potential therapeutic approach for #HIV in humans...\"\n\nAnother miracle.\n\nhttps://www.nature.com/articles/s41434-023-00410-4",
"sig": "4ae5524b2b5ab56fff2551f7cdd27ad7fb27f1b1694e33bbc78f3418924593741431a03dae6cf54a277f94a9e5636e47850fdf5efb7ef560b20a8b771590c516"
}